Roussin A - Search Results

1

Anti-analgesia of a selective NPFF2 agonist depends on opioid activity.

Roussin A, Serre F, Gouardères C, Mazarguil H, Roumy M, Mollereau C, Zajac JM. Roussin A, et al. Biochem Biophys Res Commun. 2005 Oct 14;336(1):197-203. doi: 10.1016/j.bbrc.2005.08.060. Biochem Biophys Res Commun. 2005. PMID: 16129413

2

Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.

Gelot A, Francés B, Roussin A, Latapie JP, Zajac JM. Gelot A, et al. Among authors: roussin a. Brain Res. 1998 Oct 19;808(2):166-73. doi: 10.1016/s0006-8993(98)00665-9. Brain Res. 1998. PMID: 9767158

3

Enzymatic degradation of neuropeptide FF and SQA-neuropeptide FF in the mouse brain.

Sol JC, Roussin A, Proto S, Mazarguil H, Zajac JM. Sol JC, et al. Among authors: roussin a. Peptides. 1999;20(10):1219-27. doi: 10.1016/s0196-9781(99)00126-6. Peptides. 1999. PMID: 10573294

4

Identification of neuropeptide FF-related peptides in rodent spinal cord.

Bonnard E, Burlet-Schiltz O, Francés B, Mazarguil H, Monsarrat B, Zajac JM, Roussin A. Bonnard E, et al. Among authors: roussin a. Peptides. 2001 Jul;22(7):1085-92. doi: 10.1016/s0196-9781(01)00425-9. Peptides. 2001. PMID: 11445238

5

Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.

Quelven I, Roussin A, Burlet-Schiltz O, Gouardères C, Tafani JA, Mazarguil H, Zajac JM. Quelven I, et al. Among authors: roussin a. Eur J Pharmacol. 2002 Aug 2;449(1-2):91-8. doi: 10.1016/s0014-2999(02)01983-0. Eur J Pharmacol. 2002. PMID: 12163111

6

Identification of neuropeptide FF-related peptides in human cerebrospinal fluid by mass spectrometry.

Burlet-Schiltz O, Mazarguil H, Sol JC, Chaynes P, Monsarrat B, Zajac JM, Roussin A. Burlet-Schiltz O, et al. Among authors: roussin a. FEBS Lett. 2002 Dec 18;532(3):313-8. doi: 10.1016/s0014-5793(02)03686-4. FEBS Lett. 2002. PMID: 12482585 Free article.

7

Functional consequences of neuropeptide FF receptors stimulation in mouse: a cerebral glucose uptake study.

Quelven I, Roussin A, Zajac JM. Quelven I, et al. Among authors: roussin a. Neuroscience. 2004;126(2):441-9. doi: 10.1016/j.neuroscience.2004.03.052. Neuroscience. 2004. PMID: 15207362

8

Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.

Quelven I, Roussin A, Zajac JM. Quelven I, et al. Among authors: roussin a. Eur J Pharmacol. 2005 Jan 31;508(1-3):107-14. doi: 10.1016/j.ejphar.2004.12.002. Epub 2005 Jan 7. Eur J Pharmacol. 2005. PMID: 15680260

9

Efficacy of multimodal analgesic treatment of severe traumatic acute pain in mice pretreated with chronic high dose of buprenorphine inducing mechanical allodynia.

Coutens B, Derreumaux C, Labaste F, Minville V, Guiard BP, Moulédous L, Bounes V, Roussin A, Frances B. Coutens B, et al. Among authors: roussin a. Eur J Pharmacol. 2020 May 15;875:172884. doi: 10.1016/j.ejphar.2019.172884. Epub 2019 Dec 20. Eur J Pharmacol. 2020. PMID: 31870829

10

Neutrophil-associated inflammatory responses in rats are inhibited by phenylarsine oxide.

Roussin A, Le Cabec V, Lonchampt M, De Nadaï J, Canet E, Maridonneau-Parini I. Roussin A, et al. Eur J Pharmacol. 1997 Mar 12;322(1):91-6. doi: 10.1016/s0014-2999(96)00988-0. Eur J Pharmacol. 1997. PMID: 9088876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters